News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Agere Expands cGMP Spray Dry Manufacturing Capabilities


11/6/2012 10:02:27 AM

BEND, Ore.--(BUSINESS WIRE)--Agere Pharmaceuticals, Inc., a leading oral solubilization-focused contract research and manufacturing organization (CRO/CMO), announced today that it has added the capability to support clients entering Phase IIb clinical trials with cGMP manufacturing. The new capacity extends the services to pharmaceutical companies that currently partner with Agere for formulation development to improve oral bioavailability of their BCS II and IV compounds. By expanding cGMP manufacturing services, Agere now offers its clients one-stop-shopping from concept development through manufacturing for advanced clinical trials.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES